RankingsPricing
  1. US-listed companies
  2. NORTHWEST BIOTHERAPEUTICS INC
  3. Financials
  4. Net income

NORTHWEST BIOTHERAPEUTICS INCNWBO

Market cap
$364.6M
P/E ratio
SummaryFinancials
Period EndNet income (Million USD)YoY (%)
Dec 31, 2024-84+33.83%
Dec 31, 2023-63-40.40%
Dec 31, 2022-105-158.64%
Dec 31, 2021179-133.81%
Dec 31, 2020-530+2510.37%
Dec 31, 2019-20-43.30%
Dec 31, 2018-36-51.06%
Dec 31, 2017-73-8.82%
Dec 31, 2016-80-30.09%
Dec 31, 2015-115-15.40%
Dec 31, 2014-136+106.17%
Dec 31, 2013-66-2.27%
Dec 31, 2012-67+105.06%
Dec 31, 2011-33

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)